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THE CLINICAL USE OF RADIOACTIVE PHOSOPHORUS (P32). 
I. THERAPEUTIC USE 
by 
ToKIO KuMA, SmNrcHI :.¥IrnE, RYuJI SAITO and YosHIYUKI YosHIDA 
From 2nd Sur、畠icalDivision, Kyoto University Medical School 
(Director: Prof. Dr. YAsUIA8A AoYAGI) 
Radioactive phosphorus wa日 usedfor the therapeutic purpose in 9 patients with 
malignant tumors such as a case of giantcelltumor, Hodgkins disease, oesophageal 
carcinoma, embryonal carcinoma, retroperitoneal fibrosarcoma, prostatic carcinoma, 
lymphosarcomatosis and chronic leucemia. 
The patient with pelvic giantcelltumor treated I乃F a combination of p12, 
R加tgenand Nitromin has been healthy for 18 months after the therapy. For 
Hodgkin’s disease, 0111γa single use of p~2 remained markedly effective for about 
7 months. For one case of oesophageal carcinoma and two cases of lymphosarcom-
atosis, the effect of ザ2,either combined with Rontgen therapy or not, were prov-
isionary in al cases. 
For one case of chronic leucemia, a single use of p3" has been highly effectiYe. 
The other three moribund cases with severe symptoms died before any evaluation 
of the effects of p1" could be obtained. Four out of 9 patients of this series were 
picked up and reported in detail in this paper. 
The authors emphasize that radiophosphorus therapy is available in some cases 
















放射性同位元素 p32の臨床的応用経験 971 
表
例 ｜衿 断 名｜年令及び性別｜
｜時骨巨大細胞暖 i 21才 ♀ 
2 1ホヂキン氏病 I 43才♀
3 ｜淋巴肉腫症 I 22才谷
4 ｜淋巴肉腫症 I 54才谷
5 ｜胎生癌後腹膜腔転移 1 1才合
6 I食道癌 i53才台
7 ｜後腹膜繊維肉腫 ! 72才合
s I前立腺癌 ! 70才 'CS
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SERUM HEPATITIS DUE TO BLOOD TRANSFUSION 
by 
SHOJI SuzuKI, HARUO TAKAYAMA, TAKAOKI KuRIYJ¥fdA, 
SmNzo TAKEMOTO and TERUYA TAKAsu. 
From the Surgical and Medical Division, Osaka Medical College 
(Directors : Prof. Dr. SAKもEAsADA and Prof. Dr. KYo HARA) 
Twenty seven cases of so-called serum hepatitis, experienced in our clinic during 
this 4 years, were reported. 
All of these cases were observed after the transfusion of conserved blood or 
plasma,. and morbidity revealed 5,5 per cent. 
The incubation period was from the shortest of 36 days to the longest of 186 
days. 
In preicteric stadium, all of the cases complained of general and gastrointesti-
nal subjective symptoms such as fatigue and loss of appetite, and these prodrome 
were cortsidered to be very useful to early diagnosis. 
Most of these cases recovered completely except for 5 cases: one death, one 
relapsed icterus and three chronic hepatitis. 
Liver needle biopsy findings in both cases of good and wrong prognosis were 
also demonstrated. 
者要旨は第1回日本輸血学会近畿支部総会において発表した．
